Literatur
Bruckner HW, Cohen CJ, Wallach RC, Kabakow B, Deppe G, Greenspan EM, Gusberg SB, Holland JF (1978) Treatment of advanced ovarian cancer with cis-dichloradiamine-platinum (II/: poor-risk patients with intensive prior therapy). Cancer Treatm Rep 62:555–558
Bush RS, Dembo AJ (1980) Current status of treatment for patients with ovarian cancer. In: Newman CE (ed) Ovarian cancer. Adv Biosc 26:115–135
Delclos L, Flechter GH, Rutledge F, Smith JP (1979) The role of radiation therapy in the treatment of epithelial tumors in the ovary. Referat: 12. Int. Cancer Congress. In: Thatcher, vol. VIII. Gyn. Cancer. Pergamon Press, pp 313–319
Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgensen EO, Jefferies JA, Web MJ, Kvols LK (1979) Different chemotherapeutic sensitivities and host factors affectin prognosis in advanced ovarian carcinoma versus minimal residual disease. Cancer Treat Rep 63:241–247
Ehrlich CE, Einhorn L, Williams SD, Morgan J (1979) Chemotherapy for stage III–IV epithelial ovarian cancer with cis-dichloradiammineplatinum II, Adriamycin, and cyclophosphamide: A preliminary report. Cancer Treat Rep 63:281–288
Fournier v DG, Kubli I, Bauer M, Knippenberger H (1979) Comparison of treatment results with radiogold, cobalt-60-tele-therapy and chemotherapy in 330 carcinoma of the ovary. IXth World Congr. of Gynec. and Obstet. Vortr. Nr. 130. Ref. Med. Tribune No. 18. Tokyo
Kleine W, Fuchs A, Pfleiderer A (1979) Influence of tamoxifen, danazol, gestagen and oestradiol on endometrial carcinomas and malignant ovarian tumours hetero-transplanted to NU/NU mice in regard to oestrogen and gestagen receptors. First Internat. Congr. on Hormones and Cancer, Rome, Oct. 3–6
Kleine W, Teufel G, Pfleiderer A (1979) Xenotransplantation menschlicher Ovarialkarzinome auf nu/nu Mäuse (1979). Vortr. 87. Tagg. Nordwestdtsch. Ges. Gyn., Hamburg
Malpas JS (1979) Chemotherapy in the management of ovarian carcinoma: a review. J R Soc Med 72:357–361
Pfleiderer A Jr, Kiyan S (1967) Die Behandlung des Ovarialkarzinoms in der Universitäts-Frauenklinik Tübingen seit 1957 und ihre Ergebnisse. Med Welt 18:3095–3102
Pfleiderer A (1979) Medikamentöse Therapie des Ovarialkarzinoms. Therapiewoche 29:441–420
Pfleiderer A (1980) Is chemosensitivity-testing worth-while? Report of a cooperative study. FIGO-World Congr. Tokyo. Excerpta Medica
Pfleiderer A, Teufel G, Kleine W, Ladner HA, Wrzodek W (1980) Technique and clinical relevance of pretherapeutic testing for ovarian cancer. FIGO-World Congr. Tokyo. Excerpta Medica
Rutledge F (1980) Erfahrungen in der Behandlung des Ovarialkarzinoms in USA. Vortr. München 22. 3. 80
Sauer H, Wilmanns W (1979) Ovarialkarzinom. In: Internist. Therapie maligner Erkrankungen. In: Bock, Gerok, Hartmann (eds) Klinik der Gegenwart V
Schwartz PE, Keating G, Maclusky N, Eisenfeld A (1980) Tamoxifen therapy for advanced ovarian cancer. ASCO-Meeting C443
Smith JP, Day TG Jr (1979) Review of ovarian cancer at the university of Texas systems cancer center, M. D. Anderson Hospital and tumor Institute. Am J Obstet Gynecol 135:984–993
Teufel G (1979) Proliferation von Karzinomen des weiblichen Genitale und ihre Bedeutung für die zytostatische Therapie. Habilitationsschrift. Freiburg
Teufel G, Albrecht A, Bastert G, Drings P, Geier G, Goertler K, Hohorst HJ, Kaufmann M, Klekow M, Kreienberg R, Kubli F, Mattern J, Melchert F, Neunhoeffer J, Pfleiderer A, Schmidt-Matthiesen H, Schuhmann R, Segeth G, Trams G, Vogt-Moykopf I, Volm M, Wayss K, Weber E, Wüst G (1980) Sensibilitätstestung von Ovarialkarzinomen gegen Zytostatika. Ergebnisse der koopoerativen Studiengruppe zur Sensibilitätstestung von Tumoren (KSST). Dtsch. Ges. Gyn. und Geburtshilfe. 43. Tagung, Hamburg 29. 9.–3. 10. 80.
Tobias JS, Griffiths CT (1976) Management of ovarian carcinoma. Current concepts and future prospects. N Engl J Med 294:818–823, 877–882
Vogl SE, Berenzweig M, Kaplan BH, Moukhtar M, Bulkin W (1979) The CHAD and HAD regimens in advanced ovarian cancer: Combination chemotherapy including cyclophosphamide, hexamethyl melamine, adriamycin, and cisdichlorodiamineplatinum II. Cancer Treat Rep 63:311–317
Volm M, Wayss K, Kaufmann M, Mattern J (1979) Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 15:983–994
Williams CJ, Stevenson KE, Buchanan RB, Whithouse JMA (1979) Advanced ovarian carcinoma: A pilot study of cis-dichloradiumineplatinum (II/in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients). Cancer Treat Rep 63:1745–1754
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pfleiderer, A. Referat Therapie des Ovarialkarzinoms. Arch. Gynecol. 232, 200–208 (1981). https://doi.org/10.1007/BF02429540
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02429540